Tracking LYEL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
LY
Lyell Immunopharma, Inc. (LYEL) short interest & options flow
NASDAQLyell Immunopharma reported its Q1 2026 results after the close on May 6 — EPS of -$1.10 beat the -$2.19 consensus estimate, though revenue of $2,000 came in below the $4,400 estimate. The stock enters the week down 4% and trading at $20.62, with shorts having quietly rebuilt positions over the past month and options traders leaning defensively into results. The clearest tension in…
$15.42+3.77% 1d+41.73% 1w+77.04% 1mClose: 9 Nov 2026
- Market cap
- $379M
- Next earnings
- 10 Mar 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 10 Nov 2026
LYEL news and analysis
RSSNo long-form analysis yet for LYEL. Pulse alerts and the live data picture are available on ORTEX.
Open LYEL on ORTEX →Want the live picture for LYEL?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LYEL — free to start on ORTEX.
Sign up for free →Open LYEL on ORTEX